Search Results - ji+woong+(jay)+han

3 Results Sort By:
HDAC Inhibitors for Managing Vascular Conditions and Diabetic Peripheral Neuropathies
Application Treatment of diabetic neuropathy using epigenetic modulators, histone deacetylase inhibitors (HDACis), to ameliorate or prevent vascular conditions and neuropathic pains by nerve damages. Key Benefits Reverses or protects against diabetes-induced nerve damages by direct injection of HDACi. Relatively low regulatory risk because many...
Published: 10/28/2024   |   Inventor(s): Young-Sup Yoon, Ji Woong (Jay) Han, Hyunsuk Shim
Keywords(s): Cell/Gene Therapy, Endocrinology, Metabolic Diseases, Repurposed Drug, Small Molecule
Category(s): TechPub Algolia > Therapeutics
Functional Restoration of Diabetic Bone Marrow-Derived Cells
Application Methods for restoration of diabetic bone marrow cell function for cell based therapy, using pre-existing molecules and their derivatives. Key Benefits Ability to "reactivate" diabetic bone marrow-derived stem or progenitor cells which also include peripheral blood cells such as endothelial progenitor cells. Cells are more...
Published: 7/30/2024   |   Inventor(s): Young-Sup Yoon, Ji Woong (Jay) Han
Keywords(s): Cell/Gene Therapy, Metabolic Diseases, Small Molecule
Category(s): TechPub Algolia > Therapeutics
Chemically Induced Pluripotent Stem (CiPS) Cells
Application Generation of pluripotent stem cells from adult somatic cells for medical use. Key Benefits No exogenous genetic manipulations, which minimize oncogenic effects, were observed in current methods. Peripheral blood can be used as a source of parent cell instead of fibroblasts or keratinocytes. Market Summary The economic and psychological...
Published: 7/30/2024   |   Inventor(s): Young-Sup Yoon, Ji Woong (Jay) Han, Xiaodong Cheng, Antonello Mai
Keywords(s): Cell Line, Cell/Gene Therapy
Category(s): TechPub Algolia > Therapeutics